Verastem | VSTM - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -5.94B 721M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
AstraZeneca USD 50.3B 2.96B 2026-06
Curis USD 12.71M 7.24M 2026-03
Cytokinetics USD -173.49M 653.08M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
Incyte USD 6.34B 721.58M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06
Verastem USD 81.78M 24.58M 2026-03